Zoetis (ZTS) SEC Filings: History & Chart

Zoetis Inc.(ZTS)

Drug Manufacturers - Specialty & Generic · Parsippany, NJ

$73.94-1.88 (-2.47%)

Delayed quote: Sep 8, 2026, 3:45 PM EDT

About Zoetis Inc.

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.

Parsippany, NJ

14,500 employees

www.zoetis.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Kristin C. Peck

View full financials

Form	Filing Date	Accepted	Document
4	Sep 2, 2026	Sep 2, 2026	View filing
3	Aug 24, 2026	Aug 24, 2026	View filing
4	Aug 11, 2026	Aug 11, 2026	View filing
8-K	Aug 6, 2026	Aug 6, 2026	View filing
10-Q	Aug 6, 2026	Aug 6, 2026	View filing
8-K	Aug 6, 2026	Aug 6, 2026	View filing
SC 13G/A	Jul 30, 2026	Jul 30, 2026	View filing
4	Jul 14, 2026	Jul 14, 2026	View filing
4	Jul 14, 2026	Jul 14, 2026	View filing
4	Jul 14, 2026	Jul 14, 2026	View filing
4	Jul 14, 2026	Jul 14, 2026	View filing
4	Jul 14, 2026	Jul 14, 2026	View filing
4	Jul 14, 2026	Jul 14, 2026	View filing
4	Jul 14, 2026	Jul 14, 2026	View filing
4	Jul 14, 2026	Jul 14, 2026	View filing
4	Jul 14, 2026	Jul 14, 2026	View filing
3/A	Jul 14, 2026	Jul 14, 2026	View filing
4	Jun 22, 2026	Jun 22, 2026	View filing
11-K	Jun 22, 2026	Jun 22, 2026	View filing
3	Jun 17, 2026	Jun 17, 2026	View filing
4	Jun 11, 2026	Jun 11, 2026	View filing
SD	May 28, 2026	May 28, 2026	View filing
4	May 26, 2026	May 26, 2026	View filing
8-K	May 22, 2026	May 21, 2026	View filing
4	May 21, 2026	May 21, 2026	View filing
8-K	May 20, 2026	May 20, 2026	View filing
4	May 13, 2026	May 13, 2026	View filing
4	May 13, 2026	May 13, 2026	View filing
4	May 12, 2026	May 12, 2026	View filing
10-Q	May 7, 2026	May 7, 2026	View filing

SEC Filings

Recent Filings